Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
276.33 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||||
| Net Income
| -440.242 | -1,131.156 | -852.824 | -858.281 | -886.116 | -761.497 | -490.874 | -410.108 | -290.073 | -360.395 | -89.225 | -106.014 | -57.649 | -43.515 | -47.59 | -26.249 | -85.466 | -34.608 | -42.914 | -32.654 | -25.033 | -4.136 |
| Depreciation & Amortization
| 54.054 | 85.55 | 89.694 | 74.435 | 54.368 | 6.435 | 13.367 | 15.13 | 19.05 | 11.926 | 10.229 | 9.035 | 5.125 | 4.941 | 5.992 | 5.726 | 4.082 | 3.815 | 3.119 | 2.444 | 0.838 | 0.036 |
| Deferred Income Tax
| -399.36 | 0 | -55.695 | -54.042 | -11.288 | -3.564 | 1.894 | -6.977 | 0 | -42.29 | -2.695 | -22.389 | 3.505 | 10.742 | -5.163 | -5.501 | 1.889 | -7.92 | 0 | -4.106 | 0 | 0 |
| Stock Based Compensation
| 221.68 | 230.649 | 165.717 | 139.873 | 174.841 | 157.752 | 92.819 | 75.528 | 45.783 | 33.061 | 20.703 | 12.36 | 16.796 | 19.338 | 20.168 | 18.026 | 14.472 | 8.304 | 0 | 4.106 | 0 | 0 |
| Change In Working Capital
| 10.759 | -35.553 | -162.823 | -12.701 | 402.381 | 45.099 | -2.902 | 17.219 | 35.116 | -29.401 | -8.118 | -8.965 | -55.928 | -79.56 | -50.412 | 63.9 | 254.42 | -2.655 | 16.757 | 3.482 | 2.906 | 2.65 |
| Accounts Receivables
| -87.939 | -45.597 | -101.799 | -56.236 | -24.238 | 15.242 | -10.668 | -15.036 | 31.639 | -35.689 | -4.144 | 1.364 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.31 | 0 | 0 |
| Inventory
| 18.367 | -34.136 | -26.415 | -35.426 | -32.411 | -22.645 | 10.857 | 5.397 | -0.477 | 3.293 | 0.191 | -1.811 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 80.84 | 191.769 | 88.24 | 117.376 | 36.609 | 15.478 | -4.939 | 10.098 | 1.676 | 8.84 | 1.832 | -1.736 | -3.512 | -3.177 | 9.901 | -1.238 | -0.264 | 2.088 | 0 | -0.615 | 0 | 0 |
| Other Working Capital
| -0.509 | -147.589 | -122.849 | -38.415 | 422.421 | 37.024 | 1.848 | 16.76 | 2.278 | -5.845 | -5.997 | -6.782 | -52.416 | -76.383 | -60.313 | 65.138 | 254.684 | -4.743 | 0 | 4.407 | 0 | 0 |
| Other Non Cash Items
| 657.265 | 309.236 | 174.238 | 95.755 | -12.613 | -6.841 | 2.91 | 1.507 | 0.984 | 221.458 | 0.449 | 0.364 | 1.083 | 3.713 | 4.86 | 9.589 | 7.122 | 8.434 | 6.553 | 7.158 | 8.461 | 0.172 |
| Operating Cash Flow
| 104.156 | -541.274 | -641.693 | -614.961 | -278.427 | -562.616 | -382.786 | -307.701 | -189.14 | -165.641 | -68.657 | -115.609 | -87.068 | -84.341 | -72.145 | 65.491 | 196.519 | -24.63 | -16.485 | -19.57 | -12.828 | -1.278 |
| Investing Activities: | ||||||||||||||||||||||
| Investments In Property Plant And Equipment
| -62.211 | -72.059 | -76.372 | -70.361 | -140.156 | -126.887 | -104.209 | -64.557 | -12.95 | -8.961 | -4.006 | -8.348 | -1.291 | -4.732 | -4.949 | -10.764 | -7.788 | -4.986 | -1.947 | -9.006 | -3.119 | -0.562 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25 | 0 | 0 | -81.959 | -17.838 | -10 | -0.1 | 2.342 | 0 | 40.418 | 0 | -0.121 | 0 |
| Purchases Of Investments
| -1,881.976 | -1,976.961 | -1,656.114 | -2,025.626 | -2,075.925 | -1,104.046 | -903.457 | -759.31 | -1,033.843 | -977.775 | -364.305 | -277.129 | -293.115 | -390.473 | -481.339 | -482.244 | -554.394 | -172.303 | -70.882 | -33.499 | 0 | 0 |
| Sales Maturities Of Investments
| 1,612.275 | 2,231.568 | 1,463.55 | 1,691.669 | 1,775.404 | 1,518.703 | 597.305 | 1,116.458 | 726.943 | 462.922 | 237.806 | 289.013 | 376.365 | 413.043 | 504.57 | 511.044 | 283.254 | 147.243 | 32.411 | 7.725 | 0 | 0 |
| Other Investing Activites
| -4.438 | -13.194 | -4.364 | -31.2 | 23 | -14.825 | 120 | -150 | -1.471 | -25 | -126.499 | -0.162 | 81.959 | 17.838 | 6.151 | -0.1 | -0.839 | 0 | -40.418 | 0.185 | 0 | 0 |
| Investing Cash Flow
| -336.35 | 169.354 | -273.3 | -435.518 | -417.677 | 272.945 | -290.361 | 142.591 | -321.321 | -548.814 | -130.505 | 3.374 | 81.959 | 17.838 | 14.433 | 17.936 | -277.425 | -30.046 | -40.418 | -34.595 | -3.24 | -0.562 |
| Financing Activities: | ||||||||||||||||||||||
| Debt Repayment
| 0 | -762.107 | -1,000 | -686.597 | -30 | 0 | -120 | -150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.758 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 147.464 | 259.36 | 246.268 | 99.498 | 853.184 | 68.939 | 1,161.006 | 14.301 | 616.555 | 723.037 | 173.572 | 86.8 | 0.738 | 3.663 | 3.509 | 9.913 | 61.011 | 164.89 | 52.423 | 45.308 | 27.48 | 17.345 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -3.469 | -0.257 | -0.596 | -0.378 | -15.992 | -1.389 | -0.359 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 24.667 | 928.5 | 2,000.85 | 1,582.078 | 823.184 | 68.939 | 84.142 | 164.127 | 616.555 | 752.457 | 202.315 | 6.971 | 0.738 | 3.663 | 3.509 | -1.35 | -2.376 | 1.741 | 0.194 | 5.669 | -3.772 | -0.028 |
| Financing Cash Flow
| 172.131 | 425.753 | 1,247.118 | 994.979 | 823.184 | 65.47 | 1,124.891 | 177.832 | 616.177 | 736.465 | 200.926 | 93.412 | 0.738 | 3.663 | 3.509 | 3.155 | 58.635 | 166.631 | 52.617 | 50.977 | 23.708 | 17.317 |
| Other Information: | ||||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 6.391 | -7.43 | -9.018 | 4.918 | -0.083 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.029 | -0.121 | 0.053 | -0.527 | 0.243 | -0.229 | 0.267 | 0.076 | 1.84 |
| Net Change In Cash
| -53.706 | 46.403 | 323.107 | -50.582 | 126.997 | -224.201 | 451.744 | 12.722 | 105.716 | 22.01 | 1.764 | -18.823 | -4.371 | -62.869 | -54.324 | 86.635 | -22.798 | 112.198 | -4.515 | -2.921 | 7.716 | 17.317 |
| Cash At End Of Period
| 812.688 | 868.556 | 822.153 | 499.046 | 549.628 | 422.631 | 645.361 | 193.617 | 180.895 | 75.179 | 53.169 | 51.405 | 70.228 | 74.599 | 137.468 | 191.792 | 105.157 | 127.955 | 15.757 | 20.272 | 23.193 | 15.477 |